"Patience Capital + Innovative Policies" Empowering both ends, Insurance Capital Explores a New Model of Service in Hard Technology.

As we enter the year 2026, insurance funds actively explore new ideas and methods to serve technology-based startups, increasing support for cutting-edge fields and emerging industries, demonstrating a trend of accelerating towards a dual drive model of "patient capital + innovative policies." Industry insiders indicate that on the funding side, insurance funds continuously enrich their "toolbox" by injecting "patient capital" into sectors such as integrated circuits, artificial intelligence, and biomedicine through stocks, bonds, funds, and other alternative tools, creating a comprehensive investment and financing support system. On the product side, technology insurance is constantly evolving, redefining its value in cultivating new productive forces, extending the protection chain from research and development to commercialization. Customized "innovative policies" are provided for frontier scenarios such as humanoid robots, commercial spaceflight, low-altitude economy, and generative AI, expanding the co-insurance mechanism to serve as a crucial risk "cushion" for enterprise innovation.